Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome-Reference-Cited by-同舟云学术

Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome

Published:2011-06-07 Issue:10 Volume:20 Page:1106-1108
ISSN:0961-2033
Container-title:Lupus
language:en
Short-container-title:Lupus

Author:

Sciascia S¹,Naretto C¹,Rossi D¹,Bazzan M²,Roccatello D¹

Affiliation:

1. Centro di Ricerche di Immunopatologia e Documentazione su Malattie Rare (CMID), SC a Direzione Universitaria di Immunologia Clinica, Università di Torino, Turin, Italy

2. SSD Ematologia, Dipartimento di Malattie Rare, Immunologiche, Ematologiche ed Immunoematologiche, Università di Torino, Turin, Italy

Publisher

SAGE Publications

Subject

Rheumatology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0961203311400115

Reference10 articles.

1. Comparison of Two Simple Tests for the Lupus Anticoagulant

2. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

3. Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia

4. Plasma Exchange for Thrombocytopenia in Antiphospholipid Syndrome: A Case Report

5. Management of Antiphospholipid Antibody Syndrome

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome;TH Open;2023-07

2. An update on the biologics for the treatment of antiphospholipid syndrome;Frontiers in Immunology;2023-05-19

3. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management;Autoimmunity Reviews;2022-05

4. Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS);Thrombosis and Haemostasis;2022-03-15

5. Treatment of antiphospholipid syndrome;Systemic Lupus Erythematosus;2021